Advertisement
News
Advertisement

Shire licenses central nervous system drug candidate

Tue, 03/20/2012 - 10:37am
Mass High Tech: The Journal of New England Technology

An operating company of Shire Plc. (Nasdaq: SHPGY), which has a unit in Lexington, has exercised its exclusive option to license a central nervous system drug candidate from Heptares Therapeutics of England.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading